PEDIATRICS Vol. 53 No. 3 March 1974, pp. 314-318
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olambiwonnu, N. O.
Right arrow Articles by Donnell, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olambiwonnu, N. O.
Right arrow Articles by Donnell, G. N.

Galactokinase Deficiency in Twins: Clinical and Biochemical Studies

N. Olatunji Olambiwonnu M.D.1, Robert McVie M.D.1, Won G. Ng Ph.D.1, S. Douglas Frasier M.D.1, and George N. Donnell M.D.1

1 Department of Pediatrics, University of Southern California School of Medicine, Los Angeles County-University of Southern California Medical Center, and Children's Hospital of Los Angeles

Identical twin girls with galactokinase deficiency are described. The diagnosis was made at 4 months of age when a random urinalysis in one twin showed a nonglucose reducing substance subsequently identified as galactose. Clinical findings were limited to bilateral perinuclear cataracts in both infants. There was no jaundice or hepatomegaly.

While receiving an evaporated milk formula, the urines contained large amounts of galactose and galactitol. Erythrocyte galactokinase activity was absent in both patients, and 50% of normal activity was found in both parents.

A "lactose-free" formula was instituted at 43frac12 months of age. Growth and development has been normal over 24 months of treatment. The cataracts, however, showed no significant change. Galactose and galactitol excretion was markedly decreased, but not completely eliminated. The turnover of endogenous galactose-containing compounds may be responsible for the residual galactose and galactitol excretion.

Submitted on March 22, 1973
Accepted on October 30, 1973